Kolexia
Ray Isabelle Oncologie médicale
Ray Isabelle
Oncologie médicale
Centre Léon-Bérard
Lyon, France
701 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'ovaire Sarcomes Carcinome épithélial de l'ovaire Récidive tumorale locale Carcinomes Tumeurs du sein Tumeurs des tissus mous Léiomyosarcome Tumeurs de l'endomètre

Collaborateurs

Voir plus
Blay Jean Yves
Blay Jean Yves
Centre Léon-Bérard, Lyon, France
Pautier Patricia
Pautier Patricia
Gustave-Roussy, Villejuif, France
Le Cesne Axel
Le Cesne Axel
Gustave-Roussy, Villejuif, France
Italiano Antoine
Italiano Antoine
Institut Bergonié, Bordeaux, France

Industries

Voir plus
AstraZeneca
66 collaboration(s)
Dernière en 2023
MSD
63 collaboration(s)
Dernière en 2023
GSK
51 collaboration(s)
Dernière en 2023
Clovis Oncology
28 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
BEATcc: A Randomized Phase III Trial of Platinum Chemotherapy Plus Paclitaxel With Bevacizumab and Atezolizumab Versus Platinum Chemotherapy Plus Paclitaxel and Bevacizumab in Metastatic (Stage IVB), Persistent, or Recurrent Carcinoma of the Cervix
Essai Clinique (Grupo Español de Investigación en Cáncer de Ovario)   04 mars 2024
PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
AcSé: Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
Essai Clinique (Unicancer)   26 février 2024
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN.
The Lancet regional health. Europe   16 février 2024
VICTORIA: A Multicentric, Randomized, Non Comparative, Open-label Phase I/II Evaluating AZD2014 (Dual Mammalian Target of Rapamycin Complex 1/2 (mTORC1/mTORC2) Inhibitor) in Combination With Anastrozole Versus Anastrozole Alone in the Treatment of Metastatic Hormone Receptor-positive Endometrial Adenocarcinoma
Essai Clinique (Centre Léon-Bérard)   12 février 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
IRCI Gynae Sarcomas, High Grade Uterine Sarcoma: A Randomized Double-blind Phase II Study Evaluating the Role of Maintenance Therapy With Cabozantinib in High Grade Uterine Sarcoma (HGUtS) After Stabilization or Response to Doxorubicin +/- Ifosfamide Following Surgery or in Metastatic First Line Treatment
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   05 février 2024
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.
Annals of oncology : official journal of the European Society for Medical Oncology   01 février 2024
NIRVANA-1: Randomized Study of Paclitaxel-carboplatin Followed by Niraparib Compared to Paclitaxel-carboplatin-bevacizumab Followed by Niraparib+Bevacizumab in Patients With Advanced Ovarian Cancer, Following a Front-line Complete Surgery
Essai Clinique (ARCAGY/ GINECO GROUP)   29 janvier 2024
Improved nationwide survival of sarcoma patients with a network of reference centers.
Annals of oncology : official journal of the European Society for Medical Oncology   19 janvier 2024